Full NADMED REDOX profiling was used in a Norwegian study to contribute to Parkinson’s research. Previous study conducted at the Haukeland University highlighted the clinical benefits of NR therapy for Parkinson’s patients. In this recently published paper, researchers delved into finding the optimal NR dosage to elevate NAD levels. Under exploration were the effects of high NR dosages (1500 mg twice daily). As result NR significantly increased blood NAD+ levels up to 5-fold, highlighting its efficacy in replenishing NAD metabolome. NADMED was used to measure all four forms of NAD and two glutathione, bringing precision to the forefront of the study.

Read more here!